ASND — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.6

Margin Of Safety %

-61

Put/Call OI Ratio

0.49

EPS Next Q Diff

EPS Last/This Y

14.63

EPS This/Next Y

-0.91

Price

240.5

Target Price

292.19

Analyst Recom

1.06

Performance Q

11.18

Upside

-52.1%

Beta

0.42

Ticker: ASND

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-16	ASND	242.69	0.17	0.01	20719
2026-04-17	ASND	244.61	0.17	0.17	20410
2026-04-20	ASND	245.6	0.34	0.04	8466
2026-04-21	ASND	240.68	0.34	0.02	8594
2026-04-22	ASND	231.03	0.34	0.69	8625
2026-04-23	ASND	224.83	0.36	1.37	9225
2026-04-24	ASND	229.33	0.38	0.55	9432
2026-04-27	ASND	226.93	0.39	0.04	9718
2026-04-28	ASND	222.05	0.37	0.04	10156
2026-04-29	ASND	220.13	0.33	0.07	11342
2026-04-30	ASND	229.26	0.32	0.72	11490
2026-05-01	ASND	220.77	0.35	11.73	11952
2026-05-04	ASND	228.53	0.38	0.00	12287
2026-05-05	ASND	225.22	0.34	1.74	11682
2026-05-06	ASND	235.86	0.34	0.24	11683
2026-05-07	ASND	246.06	0.37	0.19	11379
2026-05-08	ASND	238.44	0.46	0.55	10960
2026-05-11	ASND	238.46	0.49	0.44	11029
2026-05-12	ASND	237.64	0.49	0.91	11075
2026-05-13	ASND	243.7	0.49	1.22	11045
2026-05-14	ASND	245.59	0.49	0.46	11104
2026-05-15	ASND	240.44	0.49	0.02	11146
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-16	ASND	242.87	124.8	395.5	4.42
2026-04-17	ASND	244.57	124.8	397.1	4.42
2026-04-20	ASND	245.34	121.7	397.9	4.42
2026-04-21	ASND	240.40	121.7	393.1	4.42
2026-04-22	ASND	231.27	121.7	388.7	4.42
2026-04-23	ASND	224.99	121.7	382.5	4.42
2026-04-24	ASND	229.24	-	386.7	4.67
2026-04-27	ASND	226.78	-	384.2	4.67
2026-04-28	ASND	222.05	-	379.5	2.82
2026-04-30	ASND	229.34	-	386.8	2.82
2026-05-01	ASND	220.86	-	378.4	2.82
2026-05-04	ASND	228.52	-	386.0	2.82
2026-05-05	ASND	225.35	-	382.8	2.82
2026-05-06	ASND	235.89	-	396.5	2.82
2026-05-07	ASND	246.17	-	-	2.82
2026-05-08	ASND	238.51	-	-	2.82
2026-05-11	ASND	238.34	-	-	3.63
2026-05-12	ASND	237.75	-	-	3.44
2026-05-13	ASND	243.65	-	-	10.21
2026-05-14	ASND	245.38	-	-	10.21
2026-05-15	ASND	240.50	-	-	10.21
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-16	ASND	0.00	1.41	6.08
2026-04-17	ASND	0.00	1.41	6.08
2026-04-20	ASND	0.00	1.66	6.08
2026-04-21	ASND	0.00	1.66	6.08
2026-04-22	ASND	0.00	1.66	6.08
2026-04-23	ASND	0.00	1.66	6.08
2026-04-24	ASND	0.00	1.66	6.08
2026-04-27	ASND	0.00	1.93	6.01
2026-04-28	ASND	0.00	1.93	6.01
2026-04-29	ASND	0.00	1.93	6.01
2026-04-30	ASND	0.00	1.93	6.01
2026-05-01	ASND	0.00	1.93	6.01
2026-05-04	ASND	0.00	-50.00	6.01
2026-05-05	ASND	0.00	-50.00	6.01
2026-05-06	ASND	0.00	-50.00	6.01
2026-05-07	ASND	0.00	-50.00	6.01
2026-05-08	ASND	0.00	-50.00	6.01
2026-05-11	ASND	0.00	-47.30	0
2026-05-12	ASND	0.00	-47.30	4.60
2026-05-13	ASND	-3.33	-47.30	4.60
2026-05-14	ASND	-3.33	-47.30	4.60
2026-05-15	ASND	-3.33	-47.30	4.60
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

1.37

Avg. EPS Est. Next Quarter

1.21

Insider Transactions

-3.33

Institutional Transactions

-47.3

Beta

0.42

Average Sales Estimate Current Quarter

339

Average Sales Estimate Next Quarter

358

Fair Value

94.69

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

3.9

Max Drawdown 5-Year %

Target Price

292.19

P/E

27.1

Forward P/E

22.08

PEG

P/S

14.86

P/B

26.57

P/Free Cash Flow

295.38

EPS

8.87

Average EPS Est. Cur. Y

10.21

EPS Next Y. (Est.)

9.3

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

57.88

Relative Volume

0.69

Return on Equity vs Sector %

74.7

Return on Equity vs Industry %

90.2

EPS 1 7Days Diff

7.4

EPS 1 30Days Diff

10.21

EBIT Estimation

◆ ASND Healthcare

$240.50

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

2/20

Pullback

9/25

Volume

6/15

Valuation

11/20

TP/AR

5/10

Options

8/10

RSI

54.4

Range 1M

73%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

10/25

Growth

23/30

Estimates

7/20

Inst/Vol

3/15

Options

7/10

EPS Yr

431%

EPS NY

-25%

52W%

90.1%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -38.7% upside

Quality

26/30

Valuation

0/30

Growth

17/25

Stability

3/10

LT Trend

1/5

Upside

-38.7%

Quality

MoS

-61%

Ascendis Pharma A/S

Sector: Healthcare

Industry: Biotechnology

Employees: 1189

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

ASND

Latest News

—

Caricamento notizie per ASND…

stock quote shares ASND – Ascendis Pharma A/S Stock Price stock today

news today ASND – Ascendis Pharma A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch ASND – Ascendis Pharma A/S yahoo finance google finance

stock history ASND – Ascendis Pharma A/S invest stock market

stock prices ASND premarket after hours

ticker ASND fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ASND

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y